Which has grown faster, LQDA or MRVI?

Over the past five years, LQDA grew revenue faster — LQDA at a 128.77% CAGR versus MRVI at -17.68%.

Is LQDA or MRVI more profitable?

LQDA runs the higher net margin — LQDA at 30.74% versus MRVI at -37.07%.

How have LQDA and MRVI total returns compared?

Over the past 5 years, LQDA delivered 59.01% and MRVI delivered -27.63% annualized total return. Past performance doesn't predict future results.

Liquidia Corporation (LQDA) vs Maravai LifeSciences Holdings, Inc. (MRVI)

A side-by-side comparison of Liquidia Corporation and Maravai LifeSciences Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LQDA

Liquidia Corporation

$2.37B

$26.60HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT

MRVI

Maravai LifeSciences Holdings, Inc.

$2.30B

$8.31HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT

Total return — LQDA vs MRVI

growth of $100 · dividends reinvested · last 6y

LQDA +712.9% (+41.8%/yr)MRVI -71.5% (-18.9%/yr)LQDA compounded faster over this window

Log scale — wide-divergence pair

LQDA MRVI

LQDA vs MRVI: by the numbers

•LQDA is the larger company ($2.37B vs $2.30B market cap).
•LQDA is profitable (30.74% net margin) while MRVI runs a net loss (-37.07%).
•LQDA grew revenue faster over the past five years (128.77% vs -17.68% CAGR).

Metrics side by side

Valuation

Metric	LQDA	MRVI
P/E ratio	19.43	N/A
Forward P/E	10.70	N/A
P/S ratio	5.25	10.99
P/B ratio	12.12	11.22
EV / EBITDA	12.98	15.86
FCF yield	2.56%	N/A

Profitability

Metric	LQDA	MRVI
Gross margin	92.48%	17.98%
Operating margin	-32.45%	-3.63%
Net margin	30.74%	-37.07%
ROE	71.04%	-37.82%
ROIC	46.99%	16.96%

Growth (annualized)

Metric	LQDA	MRVI
Revenue CAGR (5Y)	128.77%	-17.68%
Total return CAGR (5Y)	59.01%	-27.63%

Frequently asked

Which has grown faster, LQDA or MRVI?: Over the past five years, LQDA grew revenue faster — LQDA at a 128.77% CAGR versus MRVI at -17.68%.
Is LQDA or MRVI more profitable?: LQDA runs the higher net margin — LQDA at 30.74% versus MRVI at -37.07%.
How have LQDA and MRVI total returns compared?: Over the past 5 years, LQDA delivered 59.01% and MRVI delivered -27.63% annualized total return. Past performance doesn't predict future results.

Go deeper

Full LQDA analysis Full MRVI analysis Interactive comparison tool

Dig into the metrics

Liquidia P/E ratio Liquidia ROE Maravai LifeSciences ROE Liquidia operating margin Maravai LifeSciences operating margin Liquidia revenue growth Maravai LifeSciences revenue growth Liquidia free cash flow Maravai LifeSciences free cash flow

Liquidia & Maravai LifeSciences appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.